Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Pharmacol Sci ; 138(1): 54-62, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30301597

RESUMEN

Narrowband-ultraviolet B (NB-UVB) phototherapy is used for the treatment of atopic dermatitis. Previously, we reported that irradiation with 200 mJ/cm2 of 310 nm NB-UVB suppressed phorbol-12-myristate-13-acetate (PMA)-induced up-regulation of histamine H1 receptor (H1R) gene expression without induction of apoptosis in HeLa cells. However, the effect of NB-UVB irradiation on nasal symptoms is still unclear. Here, we show that low dose irradiation with 310 nm NB-UVB alleviates nasal symptoms in toluene 2,4-diisocyanate (TDI)-sensitized allergy model rats. Irradiation with 310 nm NB-UVB suppressed PMA-induced H1R mRNA up-regulation in HeLa cells dose-dependently at doses of 75-200 mJ/cm2 and reversibly at a dose of 150 mJ/cm2 without induction of apoptosis. While, at doses of more than 200 mJ/cm2, irradiation with 310 nm NB-UVB induced apoptosis. Western blot analysis showed that the suppressive effect of NB-UVB irradiation on H1R gene expression was through the inhibition of ERK phosphorylation. In TDI-sensitized rat, intranasal irradiation with 310 nm NB-UVB at an estimated dose of 100 mJ/cm2 once a day for three days suppressed TDI-induced sneezes and up-regulation of H1R mRNA in nasal mucosa without induction of apoptosis. These findings suggest that repeated intranasal irradiation with low dose of NB-UVB could be clinically used as phototherapy of AR.


Asunto(s)
Apoptosis/efectos de la radiación , Expresión Génica/efectos de la radiación , Mucosa Nasal/patología , Mucosa Nasal/efectos de la radiación , ARN Mensajero/metabolismo , Receptores Histamínicos H1/genética , Receptores Histamínicos H1/metabolismo , Rayos Ultravioleta , Regulación hacia Arriba/efectos de la radiación , Animales , Relación Dosis-Respuesta en la Radiación , Células HeLa , Humanos , Masculino , Fototerapia , Ratas , Rinitis Alérgica/terapia
2.
Neurosci Res ; 68(4): 315-21, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20727917

RESUMEN

Non-ergot-type dopamine receptor agonists such as ropinirole are used for the treatment of Parkinson disease, but they occasionally show serious side effects including sleep attacks and daytime sleepiness. These symptoms are reminiscent of narcolepsy, a major sleep disorder. Because narcolepsy is thought to result from deficiency of a hypothalamic neuropeptide orexin, we examined whether ropinirole affected the integrity of orexin-containing neurons, using organotypic slice culture of rat hypothalamus. Application of ropinirole induced a significant decrease in the number of orexin-immunoreactive neurons. The same treatment showed no significant effect on the number of melanin-concentrating hormone-immunoreactive neurons. The decrease of orexin-immunoreactive neurons was reversible after washout of ropinirole and was not accompanied by induction of cell death. Antagonism of dopamine D(2) receptors and of serotonin 5-HT(1A) receptors attenuated the effect of ropinirole, suggesting involvement of these receptors in depletion of orexin. On the other hand, a moderate concentration of N-methyl-d-aspartate that excited orexin neurons counteracted the effect of ropinirole on the number of orexin-immunoreactive neurons. These results suggest that ropinirole can cause deficiency of orexin by inhibiting excitatory activities of orexin neurons, which may be relevant to the adverse actions of this drug on sleep and wakefulness.


Asunto(s)
Antiparkinsonianos/farmacología , Hipotálamo/efectos de los fármacos , Indoles/farmacología , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Neuronas/efectos de los fármacos , Neuropéptidos/metabolismo , Animales , Técnica del Anticuerpo Fluorescente , Hipotálamo/metabolismo , Microscopía Confocal , Neuronas/metabolismo , Orexinas , Técnicas de Cultivo de Órganos , Ratas , Ratas Wistar
3.
Peptides ; 31(6): 1131-8, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20307612

RESUMEN

A hypothalamic neuropeptide orexin (hypocretin) is a critical regulator of physiological processes including sleep/wakefulness and feeding. Using organotypic slice culture of rat hypothalamus, we found that exposure to elevated extracellular concentration of K(+) (+10-30 mM) for 24-72h led to a substantial decrease in the number of neurons immunoreactive for orexin and a co-existing neuropeptide dynorphin-A. In contrast, the same treatment affected neither the number of melanin-concentrating hormone-immunoreactive neurons nor the number of total neurons. A substantial decrease of orexin-immunoreactive neurons was also induced by 72h treatment with 1-10 microM veratridine, a Na(+) channel activator. The effect of elevated K(+) was only partially reversible, and that of veratridine was virtually irreversible, although the decrease in orexin immunoreactivity was not associated with signs of cell damage assessed by propidium iodide uptake and Hoechst 33342 nuclear staining. In addition, the level of preproorexin mRNA did not decrease during treatment with elevated K(+) or veratridine. After treatment with elevated K(+) and veratridine, c-Fos immunoreactivity appeared in orexin-immunoreactive neurons but not in melanin-concentrating hormone-immunoreactive neurons, suggesting selective excitation of orexin neurons. However, the amount of orexin released extracellularly was paradoxically decreased by treatment with elevated K(+) and veratridine. Overall, these characteristics of orexin neurons may be taken into consideration to understand the behaviors of these neurons under physiological and pathophysiological conditions.


Asunto(s)
Hipotálamo/metabolismo , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Neuropéptidos/metabolismo , Potasio/administración & dosificación , Animales , Dinorfinas/metabolismo , Hormonas Hipotalámicas/metabolismo , Hipotálamo/efectos de los fármacos , Melaninas/metabolismo , Fármacos Neuromusculares Despolarizantes/farmacología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Orexinas , Hormonas Hipofisarias/metabolismo , Proteínas Proto-Oncogénicas c-fos/biosíntesis , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Veratridina/farmacología
4.
J Neurosci Res ; 88(1): 214-21, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19610104

RESUMEN

Orexins (hypocretins) are neuropeptides produced by a small population of hypothalamic neurons whose dysregulation may lead to narcolepsy, a neurological disorder characterized by disorganization of sleep and wakefulness. Excessive stimulation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors causes preferential loss of orexin neurons in the hypothalamus, whereas an adequate level of neuronal excitatory activities is generally known to be important for the maintenance of central neurons. By examining the effect of manipulation of neural activity, we found that 24-72 hr application of tetrodotoxin (TTX) caused a substantial decrease in the number of orexin-immunoreactive neurons, but not of melanin-concentrating hormone-immunoreactive neurons, in hypothalamic slice culture. Similar results were obtained when neural activity was arrested by added extracellular Mg(2+). Reduction of orexin expression by TTX and Mg(2+) was also observed at mRNA level. The decrease of orexin-immunoreactive neurons was attributable to depletion of orexin, because it was reversible after washout of TTX or elevated extracellular Mg(2+) and was not associated with induction of cell death. Blockers of voltage-dependent Ca(2+) channels as well as of NMDA receptors also induced a significant and selective decrease of orexin-immunoreactive neurons. Moreover, TTX-induced decrease of orexin immunoreactivity was largely abrogated by concurrent application of a moderate concentration of NMDA. These results suggest that Ca(2+) entry associated with nontoxic levels of spontaneous activity of glutamatergic inputs plays an important role in the maintenance of orexin neurons in a tissue culture model.


Asunto(s)
Hipotálamo/metabolismo , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Inhibición Neural/fisiología , Neuronas/metabolismo , Neuropéptidos/metabolismo , Análisis de Varianza , Animales , Calcio/metabolismo , Canales de Calcio/metabolismo , Recuento de Células , Muerte Celular/fisiología , Técnica del Anticuerpo Fluorescente , Hormonas Hipotalámicas/metabolismo , Hipotálamo/efectos de los fármacos , Péptidos y Proteínas de Señalización Intracelular/genética , Melaninas/metabolismo , N-Metilaspartato/farmacología , Neuronas/efectos de los fármacos , Neuropéptidos/genética , Orexinas , Técnicas de Cultivo de Órganos , Hormonas Hipofisarias/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Receptores de N-Metil-D-Aspartato/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología , Tetrodotoxina/farmacología , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA